USANA Health Sciences (USNA) Reaches New 52-Week High and Low at $100.45

Shares of USANA Health Sciences, Inc. (NYSE:USNA) hit a new 52-week high and low during trading on Friday . The company traded as low as $100.45 and last traded at $100.35, with a volume of 59586 shares trading hands. The stock had previously closed at $99.65.

A number of analysts have commented on the stock. Pivotal Research boosted their price target on shares of USANA Health Sciences from $80.00 to $95.00 and gave the company a “buy” rating in a research note on Wednesday, February 7th. TheStreet downgraded shares of USANA Health Sciences from a “b+” rating to a “c+” rating in a report on Tuesday, February 6th. Finally, Sidoti downgraded shares of USANA Health Sciences from a “buy” rating to a “neutral” rating in a report on Wednesday, January 24th.

How to Become a New Pot Stock Millionaire

The firm has a market capitalization of $2,404.94, a PE ratio of 24.51 and a beta of 0.82.

USANA Health Sciences (NYSE:USNA) last posted its quarterly earnings data on Tuesday, February 6th. The company reported $1.11 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $1.00 by $0.11. The firm had revenue of $273.11 million for the quarter, compared to the consensus estimate of $258.67 million. USANA Health Sciences had a net margin of 5.97% and a return on equity of 27.08%. The business’s revenue for the quarter was up 8.0% compared to the same quarter last year. During the same period in the previous year, the firm earned $0.87 EPS. equities research analysts expect that USANA Health Sciences, Inc. will post 4.25 EPS for the current fiscal year.

In related news, major shareholder Global Ltd Gull sold 2,753 shares of the business’s stock in a transaction dated Friday, February 2nd. The shares were sold at an average price of $74.24, for a total value of $204,382.72. Following the transaction, the insider now directly owns 11,682,053 shares of the company’s stock, valued at approximately $867,275,614.72. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. Also, Director Myron W. Wentz sold 228,000 shares of the business’s stock in a transaction dated Monday, March 12th. The stock was sold at an average price of $81.10, for a total transaction of $18,490,800.00. The disclosure for this sale can be found here. Insiders have sold a total of 729,767 shares of company stock worth $58,024,833 over the last ninety days. Insiders own 53.20% of the company’s stock.

Hedge funds and other institutional investors have recently added to or reduced their stakes in the business. US Bancorp DE lifted its holdings in USANA Health Sciences by 730.1% during the fourth quarter. US Bancorp DE now owns 2,374 shares of the company’s stock valued at $176,000 after purchasing an additional 2,088 shares during the last quarter. Cubist Systematic Strategies LLC purchased a new stake in USANA Health Sciences during the third quarter valued at about $189,000. Creative Planning purchased a new stake in USANA Health Sciences during the fourth quarter valued at about $219,000. Hikari Power Ltd purchased a new stake in USANA Health Sciences during the fourth quarter valued at about $255,000. Finally, Stone Ridge Asset Management LLC purchased a new stake in USANA Health Sciences during the fourth quarter valued at about $265,000. 48.28% of the stock is currently owned by institutional investors and hedge funds.

TRADEMARK VIOLATION NOTICE: This report was reported by The Lincolnian Online and is owned by of The Lincolnian Online. If you are viewing this report on another site, it was copied illegally and republished in violation of United States and international copyright legislation. The legal version of this report can be viewed at https://www.thelincolnianonline.com/2018/04/20/usana-health-sciences-usna-reaches-new-52-week-high-and-low-at-100-45.html.

About USANA Health Sciences

USANA Health Sciences, Inc develops and manufactures science-based nutritional and personal care products. The Company operates as a direct selling company in two geographic regions: Americas and Europe, and Asia Pacific, which includes three sub-regions: Southeast Asia Pacific, Greater China and North Asia.

Receive News & Ratings for USANA Health Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for USANA Health Sciences and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply